IMPRiND Project

New publication in Acta Neuropathologica

Elevation of p-Tau in CSF is linked to the aggregation of amyloidogenic proteins rather than a unique feature of β-amyloidosis and can occur independently of neurofibrillary tangles. Provocative and impressive findings from Stephan Käser from the DZNE team.

Publication in Nature by the LMB team

The paper on "Structure-based classification of Tauopathies", by Michel Goedert and his colleagues at LMB, is now online at @nature.

To learn more about it.

New paper in the Molecular Neurodegeneration journal

Induced αS lesions in mouse and human brain cultures. This publication from the DZNE team shows that now we can study such lesions in a true aged human brain environment. A key finding for developing therapeutics to delay or halt disease progression.

Read it here

RESEARCH HIGHLIGHT – A stem cell-based model offers new insights into the mechanisms of neuronal loss in Parkinson’s disease

Dr Tofaris and his team at UOXF in collaboration with Ronald Melki (CNRS) have now come up with a working laboratory model. They used induced pluripotent stem cells (iPSC) derived from both healthy subjects and patients with the alpha-synuclein gene defects to generate human dopaminergic neurons that are primarily affected in Parkinson’s disease. They found a way of ‘amplifying’ in a fairly pure form, the main constituent, called fibril, of alpha-synuclein clumps directly from post-mortem Parkinson’s brains. When they added these brain-derived fibrils onto the human dopaminergic neurons, they successfully triggered the aggregation of alpha-synuclein inside the cells and observed progressive neuronal loss.

Reporting in Nature Communications, Tanudjojo et al. used this model to show that the two main determinants of neuronal death are: (a) the abundance of alpha-synuclein inside nerve cells, and (b) the structure it acquires when it assembles into aggregates. By tracking the molecular interactions of the toxic forms of alpha-synuclein aggregates in living cells, they discovered that they cause damage partly by evading the protective effects of PARK7/DJ-1. Deletion of DJ-1 in iPSC-derived neurons increased alpha-synuclein aggregation and neuronal death. This could explain why loss of function mutations in DJ-1 in patients causes Parkinson’s disease.

Read more

Publication of an IMPRiND Nature Comm. paper

A great IMPRiND achievement: Nature Comm. paper on α-synuclein strain effects in iPSC-dopaminergic neurons.

Read it here

Show more posts

This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking ( under grant agreement No 116060. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 17.00038.

The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.

© 2019 IMPRiND Project – created by SCIPROMPrivacy policy